Suppr超能文献

在无甲泼尼龙情况下使用TAO治疗重度哮喘。

Use of TAO without methylprednisolone in the treatment of severe asthma.

作者信息

Rosenberg S M, Gerhard H, Grunstein M M, Schramm C M

机构信息

Division of Pulmonary Medicine, Children's Hospital of Philadelphia.

出版信息

Chest. 1991 Sep;100(3):849-50. doi: 10.1378/chest.100.3.849.

Abstract

The antimicrobial agent troleandomycin (TAO) has been shown to be effective in reducing corticosteroid requirements in patients with corticosteroid-dependent asthma. To our knowledge, the efficacy of TAO without concomitant use of corticosteroids has never been documented. We report the case of a 12-year-old patient with corticosteroid-dependent asthma who has remained asymptomatic and without any evidence of pulmonary deterioration during treatment with TAO without concomitant use of corticosteroids.

摘要

抗菌药物曲古霉素(TAO)已被证明在减少依赖皮质类固醇激素的哮喘患者对皮质类固醇激素的需求方面有效。据我们所知,从未有文献记载TAO在不联合使用皮质类固醇激素时的疗效。我们报告了一例12岁依赖皮质类固醇激素的哮喘患者,该患者在使用TAO且未联合使用皮质类固醇激素治疗期间一直无症状,且无任何肺部恶化的迹象。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验